Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Supplemental creatine may help bolster muscle energy reserves and produce modest strength and fatigue improvements in ALS patients, though clinical trials have shown mixed results and no clear survival benefit. It is generally well tolerated at typical doses but requires monitoring for side effects such as gastrointestinal discomfort and changes in kidney markers.
There are several factors to consider, including disease stage, dosing protocols and how creatine fits into a comprehensive ALS care plan. See below for complete evidence, practical dosing guidelines and safety considerations.
ALS Support: Can Supplemental Creatine Support Muscle Function?
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that attacks motor neurons, leading to muscle weakness, twitching and eventual loss of voluntary movement. As muscle fibers lose nerve input, patients face growing difficulty with daily tasks, breathing and swallowing. While there is no cure, researchers continue to explore supportive strategies that may help preserve muscle function, delay declines and improve quality of life.
One supplement that has attracted attention is creatine. Best known in sports nutrition, creatine plays a key role in energy metabolism. But can supplemental creatine ease ALS symptoms? Below, we review what creatine is, the science behind "creatine and ALS symptoms," potential benefits, safety considerations and practical dosing tips.
Creatine is a natural compound synthesized in the liver, kidneys and pancreas from amino acids glycine, arginine and methionine. About 95% of the body's creatine is stored in skeletal muscle, where it combines with phosphate to form phosphocreatine—a rapidly mobilized energy reserve. During short bursts of high-intensity activity, phosphocreatine donates its phosphate to ADP to regenerate ATP, the primary cellular energy currency.
Because ALS compromises the nerves that trigger muscle contractions, energy supply to muscle fibers can become disrupted. The hypothesis: boosting creatine stores might help struggling muscles maintain function for longer.
Researchers have explored creatine in both laboratory (preclinical) models of ALS and in human clinical trials. Key findings include:
• Preclinical Studies
– In SOD1 mouse models of ALS, creatine supplementation (2–5% of diet) slowed motor neuron degeneration and extended survival by up to 10–20%.
– Improvements in muscle force production were observed, suggesting enhanced muscle bioenergetics.
• Phase II Human Trials
– A small 2001 study (9 months, 12 g/day) reported modest gains in handgrip strength and delayed functional decline compared to placebo.
– Minor improvements in fatigue and daily activities were noted, though not all reached statistical significance.
• Phase III Human Trials
– A larger 2003 trial (9 months, 10 g/day) found no significant effect on overall survival or global disease progression.
– Secondary outcomes hinted at slight strength benefits in certain muscle groups.
• Meta-Analyses
– Reviews pooling multiple trials conclude that creatine is generally safe in ALS patients and may offer small improvements in muscle strength, but evidence is insufficient to confirm a clear survival advantage.
Overall, research suggests that creatine can bolster muscle energy stores and, in some cases, modestly improve strength or slow functional decline. However, results are variable and not all patients respond equally.
When considering "creatine and ALS symptoms," potential advantages include:
• Enhanced Muscle Energy
– By increasing phosphocreatine availability, supplemental creatine may help muscles generate ATP more efficiently during everyday tasks.
• Mitochondrial Support
– Creatine has antioxidant properties that may protect mitochondria from oxidative stress—a factor implicated in ALS progression.
• Maintenance of Lean Mass
– Some patients experience less muscle wasting and a smaller decline in lean body mass.
• Improved Fatigue Management
– Even small gains in energy metabolism can reduce the exhaustion that accompanies daily activities.
These effects may translate into better performance on physical therapy exercises, longer endurance for walking or transfers and overall better quality of life.
Creatine is one of the most extensively studied dietary supplements. In the context of ALS:
• Generally Well-Tolerated
– Studies up to 12 g/day for nine months report few serious adverse events.
• Common Mild Side Effects
– Gastrointestinal discomfort (bloating, cramping)
– Weight gain due to water retention in muscle tissue
• Kidney Function
– Although creatinine (a creatine breakdown product) levels rise, creatine itself has not been shown to damage healthy kidneys.
– Patients with preexisting kidney disease should use creatine cautiously and have renal function monitored.
• Drug Interactions
– Rarely, potential interactions with diuretics or nonsteroidal anti-inflammatory drugs (NSAIDs) have been noted. Always review supplements with your healthcare provider.
If you and your doctor decide to try creatine, here are common approaches used in trials:
• Loading Phase (Optional)
– 15–20 g/day (divided into 3–4 doses) for 5–7 days to saturate muscle stores quickly.
• Maintenance Phase
– 3–5 g/day thereafter to keep creatine levels elevated.
• Timing
– Take with meals to enhance absorption.
– Mix with water, juice or a carbohydrate-containing beverage.
• Product Quality
– Choose a pharmaceutical- or USP-grade creatine monohydrate for purity and minimal contaminants.
While creatine holds promise, it is important to understand its limits:
• Not a Cure
– Creatine can at best be supportive; it does not reverse motor neuron loss or halt ALS progression.
• Variable Response
– Individual benefits vary widely. Factors include disease stage, muscle mass and genetics.
• Ongoing Research
– Future trials may explore combinations (e.g., creatine plus antioxidants) or novel creatine analogues for stronger effects.
• Holistic Care
– Creatine should complement, not replace, standard ALS therapies, including FDA-approved medications, physical therapy, respiratory support and nutritional management.
To maximize muscle function and overall wellbeing:
• Multidisciplinary Care
– Work with neurologists, physical therapists, dietitians and speech therapists.
• Exercise and Stretching
– Gentle, guided exercises maintain flexibility and slow atrophy without overfatiguing muscles.
• Nutritional Support
– Adequate calories and protein help preserve lean mass; high-calorie supplements may be needed if swallowing is difficult.
• Respiratory Monitoring
– Early use of noninvasive ventilation can reduce fatigue and improve quality of life.
If you're experiencing unexplained muscle weakness, persistent twitching or difficulty with movement, use this free AI-powered Amyotrophic Lateral Sclerosis (ALS) symptom checker to better understand your symptoms and determine whether you should seek medical evaluation. Early diagnosis is crucial for accessing supportive treatments and clinical trials.
Supplemental creatine represents one piece of a comprehensive care plan. Its safety profile and potential to support muscle energy make it worth discussing with your healthcare team—especially in the context of "creatine and ALS symptoms."
Always speak to a doctor or specialist before starting any new supplement, particularly for conditions as serious as ALS. Prompt medical guidance ensures that all aspects of your care—from life-threatening risks to quality-of-life improvements—are managed safely and effectively.
(References)
* Martin S, Ringer C, Nagel A, Grehl T, Petri S, Zierz S, Dengler R, Löscher WN. Creatine for amyotrophic lateral sclerosis (ALS). Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005221. doi: 10.1002/14651858.CD005221.pub3. PMID: 28612502.
* Shukla D, Gautam N, Garg V, Verma S, Sanyal S, Kumar M, Gupta A. Creatine and Amyotrophic Lateral Sclerosis: A Brief Review. J Exp Neurosci. 2020 Sep 28;14:1179069520960537. doi: 10.1177/1179069520960537. PMID: 33051759; PMCID: PMC7527637.
* Ahmadian M, Moradian F, Moradian N, Afshari M, Abedi M, Alizadeh N, Momeni HR. Creatine supplementation and its role in improving muscular function in neurological disorders. Neural Regen Res. 2021 Mar;16(3):477-485. doi: 10.4103/1673-5374.293149. PMID: 33057118; PMCID: PMC7778949.
* Alasvand Z, Hossein-Khannazer N, Saedisomeh S, Nami M. Emerging roles of creatine in neurological diseases. Cell Mol Life Sci. 2023 Feb 18;80(3):71. doi: 10.1007/s00018-023-04706-5. PMID: 36799017; PMCID: PMC9939527.
* Maleki M, Ebrahimi V. Creatine for neuroprotection and treatment of neurological disorders: a review of the state of the art. Amino Acids. 2020 Jan;52(1):15-32. doi: 10.1007/s00726-019-02796-0. PMID: 31802379.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.